Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization
Open Access
- 16 January 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 10 (2), 164-170
- https://doi.org/10.1093/europace/eum289
Abstract
To evaluate the impact of Home Monitoring™(HM) remote control on patient medical treatment and on health-care resource utilization. One hundred and seventeen patients received HM pacemakers or defibrillators. A pacing expert nurse consulted daily the website and submitted critical cases to physician. During a mean follow-up of 227 ± 128 days, 25 210 messages were received (23 545 daily messages and 1665 alert events) resulting in 90.7% of HM supervised days. Fifty-nine minutes/week for the nurse and 12 min/week for the physician were spent for HM data analysis during 267 web-connections. The mean connection time per patient was 115 ± 60 s. The nurse submitted to the physician 133 critical cases in 56 patients. The diagnosis were atrial fibrillation (47%), ventricular tachyarrhythmias (9%), inappropriate implantable cardioverter defibrillator intervention (4%), unsustained ventricular tachycardia (7%), device suboptimal programming (23%), and impending heart failure (10%). Sixty-six unplanned follow-up in 43 patients led to drug therapy change (44%), device reprogramming (18%), diagnosis confirmation without further intervention (24%), no confirmation (6%), further diagnostic tests (9%). HM technology allowed optimization of medical treatment and device programming with low consumption of health-care resource.Keywords
This publication has 1 reference indexed in Scilit:
- Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia PacemakersJournal of the American College of Cardiology, 2005